Top Abstract Purchase Related
Home
>
Node
>
Subnode

Regulatory science promoting improvement in developing environment of innovative drugs

Kawanishi, T.

Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 131: 2-6

2013

ISSN/ISBN: 1343-4292
PMID: 24340663
Document Number: 668905
Importance of regulatory science in development of innovative drugs is pointed out by the Council for Science and Technology Policy in the Cabinet Office, and the pharmaceuticals-related divisions in the NIHS have begun the regulatory science research for promoting improvement in developing environment of innovative drugs since 2012. Nano-medicines, fully engineered protein drugs, nucleic acid drugs, and gene therapy drugs have been selected as innovative drugs, and the point-to-consider documents for evaluating mainly quality and non-clinical safety of these drugs will be developed. In addition, the conditions for the first-in-human trial will be also proposed, especially from the standpoints of quality and non-clinical safety evaluation.

Document emailed within 1 workday
Secure & encrypted payments

Berkner, S.; Konradi, S.; Schönfeld, J. 2014: Antibiotic resistance and the environment--there and back again: Science & Society series on Science and Drugs EMBO reports 15(7): 740-744
Philliber, S.; Nolte, K. 2008: Implementation science: promoting science-based approaches to prevent teen pregnancy Prevention Science: the Official Journal of the Society for Prevention Research 9(3): 166-177
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Panicker, G.K.; Karnad, D.R.; Salvi, V.; Kothari, S. 2012: Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs Journal of the Association of Physicians of India 60: 56-61
Hayakawa, T. 2003: Potential role of regulatory science in the development of novel biologics Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 121: 128-143
Schwetz, B.A. 2001: U.S. Food and Drug Administration--a science-based regulatory agency Journal - Association of Official Analytical Chemists 84(1): 171-175
Crommelin, Daan, J.A. 1999: Science and the regulatory process A report on the group discussion sessions Pharmacy and Pharmacology Communications 5(1): 3-5
Allen, P.; Piselli, C.; Friedman, G. 2006: Staying ahead in a changing regulatory environment Healthcare Financial Management: Journal of the Healthcare Financial Management Association 60(11): 109-110
Takeichi, N.; Umemura, T.; Katsuno, M.; Nishimura, J.; Motomura, S.; Ibayashi, H. 1987: Regulatory roles of burst-promoting activity (BPA) from bone marrow cells during human regenerating hemopoiesis Experimental Hematology 15(7): 790-796
Sibley, L.; Buffington, S.T.; Beck, D.; Armbruster, D. 2001: Home based life saving skills: promoting safe motherhood through innovative community-based interventions Journal of Midwifery and Women's Health 46(4): 258-266
Bachner, P. 1992: Quality improvement in the modern clinical laboratory: the regulatory and accreditation perspective Disease Markers 10(1): 27-35
Livingston, I.L. 1992: AIDS/HIV crisis in developing countries: the need for greater understanding and innovative health promotion approaches Journal of the National Medical Association 84(9): 755-770
Arrowood, D.; Bailey-Woods, L.; Easterling, S.; Endicott, M.; Love, T.; McDonald, L.; Rhinehart, E.; Wieczorek, M. 2015: Best Practices in the Art and Science of Clinical Documentation Improvement Journal of Ahima 86(7): 46-50
Halfacre, A.C.; Owens, K.A.; Zimmerman, K.S.; Hart, Z.H. 2004: The Green Building Project: Promoting Political Science Learning through a Collaborative Research Approach Political Science and Politics 37(02): 297-302
Stern, P.C. 1993: A second environmental science: human-environment interactions Science 260(5116): 1897-1899
1991: A call for action: promoting health in developing countries. World Health Organization: Working Group on Health Promotion in Developing Countries Health Education Quarterly 18(1): 5-15
1991: A call for action: promoting health in developing countries. World Health Organization: Working Group on Health Promotion in Developing Countries Health Education Quarterly 18(1): 5-15
Henley, C.; Forgwei, G.; Welty, T.; Golden, M.; Adimora, A.; Shields, R.; Muffih, P.Tih. 2013: Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries Sexually Transmitted Diseases 40(12): 909-914
Reid, J.L. 2002: Lifesaving strategies. Promoting a safe working environment rewards the construction industry Occupational Health and Safety 71(11): 16
De Wit Greene, A.G. 1973: Promoting and developing activities of a public health program Salud Publica de Mexico 15(6): 831-837